Cionic Neural Sleeve safety and ease of use for Parkinson's gait

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will have people with Parkinson's and self-reported gait impairment try the Cionic Neural Sleeve Multistim System, a wearable device that delivers stimulation to the legs. Participants must be able to walk for up to one minute and have a compatible smartphone with Bluetooth and internet access to run the device. The study focuses on safety outcomes and usability metrics rather than long-term efficacy, and excludes people with daily falls, implanted demand-type pacemakers or defibrillators, or certain leg conditions. Visits are conducted at two California sites where device fitting and monitoring will occur.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Self-reported gait impairment
* Have access to a smartphone with iOS or Android operating system with Bluetooth capabilities and internet connection
* Ability to walk with or without an assistive device for up to 1 minute
* Leg measurements within sizing range of the Cionic Neural Sleeve

Exclusion Criteria:

* Daily occurrence of falls
* Implanted demand-type cardiac pacemaker or defibrillator
* Malignant tumor or existing thrombosis in the leg
* Fracture or dislocation in the leg that could be adversely affected by motion from stimulation

Where it's running

• Adapt Movement
  Carlsbad, California, United States Recruiting
• Cionic
  San Francisco, California, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Parkinson’s Risk in Gaucher Disease Type 1

  This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.

  Recruiting Icahn School of Medicine at Mount Sinai · New York, New York · NCT07886879

• Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s

  In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.

  Recruiting University Ghent · Ghent, Oost-Vlaanderen · NCT07863219

• Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS

  This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.

  Recruiting University Health Network, Toronto · Toronto, Ontario · NCT07846007

• Capacitive-resistive radiofrequency therapy for people with Parkinson's disease

  This study tests four TECAR therapy protocols on the legs to see which best reduces muscle stiffness and improves walking in people with Parkinson's disease.

  Recruiting Universidad San Jorge · Zaragoza, Zaragoza · NCT07842926

• TRB-001 safety and immune response in early Parkinson's disease

  This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.

  Recruiting Phase 1 Tridem Bioscience FlexCo · Vienna · NCT07840027

• Bayesian optimization to tune DBS for better gait in Parkinson’s patients

  This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.

  Recruiting Early Phase 1 University of Minnesota · Minneapolis, Minnesota · NCT07835308

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.